U.S. Other Utilities Stock News

Cabot (CBT) recently signed a multi year supply agreement with PowerCo SE for conductive carbons and dispersions used in EV battery electrodes, putting fresh attention on how this business might shape the stock. See our latest analysis for Cabot. The PowerCo agreement has come as Cabot’s 1 month share price return of 4.9% contrasts with a weaker 1 year total shareholder return of 23.2% and a modest 5 year total shareholder return of 71.7%. This suggests recent momentum is building from a...

If you are wondering whether Royal Gold's recent run means the stock is now expensive or still offers value, this article will walk through what the current price could imply. Royal Gold's share price recently closed at US$277.70, with returns of 9.3% over 7 days, 22.0% over 30 days, 25.6% year to date, 99.2% over 1 year, 124.2% over 3 years and 182.8% over 5 years. Recent price moves in Royal Gold have played out against an ongoing focus on the precious metals sector and how royalty and...

If you are looking at Qorvo and wondering whether the current share price reflects fair value or an opportunity, you are not alone. The stock last closed at US$79.85, with returns of a 0.5% decline over 7 days, a 6.8% decline over 30 days, a 7.4% decline year to date and an 8.8% decline over 1 year, alongside longer term returns of a 26.1% decline over 3 years and a 54.4% decline over 5 years. Recent attention on Qorvo has centered on how these share price moves fit with its position in the...

Option Care Health (OPCH) has drawn fresh attention after expanding its share repurchase authorization to US$1b, completing earlier buybacks, and issuing full year 2026 net revenue guidance of US$5.8b to US$6.0b. See our latest analysis for Option Care Health. Those announcements come after a strong run in the share price, with a 30 day share price return of 10.09% and a 90 day share price return of 26.51%, while the 1 year total shareholder return of 21.45% and 5 year total shareholder...

Neogen (NEOG) has attracted fresh attention after recent share price moves, with the stock closing at US$9.35 and showing mixed return patterns across the past year and the past 3 months. See our latest analysis for Neogen. The recent 30 day share price return of 29.86% and 90 day share price return of 52.28% contrast with a 1 year total shareholder return decline of 20.36%. This suggests short term momentum has picked up while longer term holders have still faced weaker outcomes. If Neogen's...

Nuvation Bio Inc. and Eisai Co. Ltd. recently signed an exclusive license and collaboration agreement that grants Eisai rights to develop, register and commercialize taletrectinib (IBTROZI) for ROS1-positive non-small cell lung cancer across Europe, the Middle East, North Africa, Russia, Turkey, Canada, Australia, New Zealand and multiple Asian markets, in exchange for an upfront payment of €50 million (about US$60 million), potential milestones up to €145 million (about US$170 million) and...

Dorman Products has reshaped its senior leadership team, appointing Charles W. Rayfield as CFO-designate, Nathan J. Porter as COO, and new presidents for its Light Duty and Heavy Duty segments as of January 19, 2026. The moves not only refresh the C-suite but also align finance, operations, and segment leadership around a unified growth and execution agenda. We’ll now examine how this broad leadership refresh, particularly the new COO role, influences Dorman’s longer-term investment...

Why Wyndham Hotels & Resorts (WH) is back on investors’ radar Wyndham Hotels & Resorts (WH) has drawn fresh attention after accelerating its push into Asia, opening Wyndham Goseong Gangwon in South Korea and adding new franchise deals in Seoul, Busan and China. For you as an investor, this cluster of openings and agreements raises direct questions about how a larger international mix might influence Wyndham’s fee based earnings, overall growth profile and the way the market prices its...

Earlier this month, National Vision Holdings, Inc. reaffirmed its earnings guidance for the 53 weeks ended January 3, 2026, maintaining expected net revenue between US$1.97 billions and US$1.99 billions. This confirmation of the revenue outlook reinforces management’s confidence in the company’s operating trajectory and offers investors increased clarity on near-term expectations. Next, we’ll examine how National Vision’s decision to reaffirm full-year earnings guidance shapes the company’s...

Lindsay Corporation (NYSE:LNN) has appointed Brett R. Coburn as Chief Accounting Officer. The leadership change affects responsibility for the company’s accounting, financial reporting, and internal controls. Investors may watch this appointment for any impact on Lindsay’s governance and financial oversight. Lindsay, trading at $122.99, has seen mixed share performance in recent years, with a 1.5% year-to-date return and a 1-year return of an 8% decline. Over 3 and 5 years, returns of a...

In recent weeks, Rocket Companies has been in focus as a US$200 billion government-backed purchase of mortgage-backed securities has boosted refinancing activity and attention on mortgage finance firms. At the same time, Redfin, powered by Rocket, has highlighted a rare housing backdrop with far more sellers than buyers and only modest home-price gains, underscoring shifting conditions across the U.S. market. Against this backdrop, we’ll examine how the government-backed mortgage purchase...

The U.S. FDA recently issued draft guidance allowing minimal residual disease and complete response to be used as endpoints for accelerated approval in multiple myeloma therapies, a framework that directly affects Arcellx’s anito-cel program with Kite Pharma. This regulatory shift may meaningfully influence how Arcellx designs and interprets its clinical trials, potentially reshaping timelines and evidence thresholds for its multiple myeloma candidate. We’ll now examine how the FDA’s focus...

As the United States market experiences a rebound following recent volatility, with major indices like the Dow Jones and S&P 500 showing significant gains after addressing geopolitical tensions, investors are keeping a close eye on high-growth sectors. In this dynamic environment, identifying tech stocks with strong fundamentals and innovative potential can be crucial for navigating the opportunities presented by such market fluctuations.

Amid recent volatility in the U.S. markets, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations due to geopolitical tensions and economic policy shifts, investors are keenly observing opportunities that may arise from these movements. In such an environment, identifying stocks that are potentially undervalued based on intrinsic value estimates can offer a strategic advantage, as they might provide growth potential when market conditions stabilize.

As the U.S. stock market rebounds from recent turbulence, driven by geopolitical tensions and economic policy shifts, investors are closely monitoring growth companies that exhibit strong fundamentals and resilience. In this context, high insider ownership combined with robust revenue growth can be a compelling indicator of confidence in a company's future prospects, making it an attractive consideration for those navigating today's complex market landscape.

Major stock indexes saw a significant rebound recently, with the Dow Jones adding 450 points after President Trump ruled out the use of force in Greenland. Amidst this backdrop of market volatility and geopolitical tensions, investors are exploring opportunities beyond traditional stocks. Penny stocks, often representing smaller or newer companies, continue to attract attention for their potential value and growth prospects. In this article, we explore three penny stocks that showcase...

As the United States market navigates a landscape marked by recent volatility, with major indices like the Dow Jones and S&P 500 experiencing significant fluctuations, investors are increasingly attentive to small-cap stocks that may offer unique opportunities. In this environment, identifying promising small-cap companies requires a keen eye for those with strong fundamentals and potential for growth despite broader economic uncertainties.

Community Trust Bancorp, Inc. reported past fourth-quarter 2025 net interest income of US$58.12 million and net income of US$27.28 million, contributing to record full-year earnings supported by higher net interest income and disciplined expenses. An interesting takeaway is that the bank paired this profit growth with an increased quarterly dividend of US$0.53 per share, underlining its focus on returning cash to shareholders. Next, we’ll examine how this record earnings performance,...

Intro Galaxy Digital (GLXY) has been drawing attention after a period of mixed returns, including a 6.4% decline over the past day, a 19.7% gain over the past week, and a 14.0% decline over the past 3 months. See our latest analysis for Galaxy Digital. That mix of a 33.8% 1 month share price return alongside a 14.0% 3 month share price decline suggests recent momentum is picking up again, as reflected in a 29.7% year to date share price return and a very large 3 year total shareholder...

Corporación América Airports (CAAP) is back in focus after its affiliate received US$91.2 million related to an ICSID arbitration award, while 2025 traffic data showed higher passenger volumes and new annual records across several markets. See our latest analysis for Corporación América Airports. The arbitration cash inflow and record 2025 traffic figures arrive after a sharp 46.74% 3 month share price return, while the 1 year total shareholder return of 32.28% points to momentum that has...

Earlier in January 2026, V2X, Inc. announced it had been awarded a place on the Missile Defense Agency’s SHIELD IDIQ contract vehicle, which carries a ceiling of US$151 billion and supports rapid, innovative homeland defense solutions aligned with the Golden Dome American program. This award, combined with the recent addition of three defense and technology veterans to its expanded Board, underscores V2X’s growing role in advanced national security and mission‑critical technology...

H&R Block (HRB) just made a tax season move that could matter for its stock story, offering Tax Pro Review at no extra cost to new paid DIY online clients through February 15 in light of more complex 2025 tax rules. See our latest analysis for H&R Block. Despite the new Tax Pro Review offer and an upcoming earnings update in early February, H&R Block’s share price has faced pressure recently. The 90 day share price return is 23.28% and the 1 year total shareholder return is 24.46%, while the...

UFP Industries recently reported that unit sales have fallen over the past two years, with earnings per share dropping faster than revenue and returns on capital slipping, pointing to past profit pools becoming harder to sustain. This combination of weaker volumes, compressed earnings, and declining capital efficiency raises fresh questions about how durable the company’s profit engine may be. Next, we’ll examine how the ongoing slide in earnings per share shapes UFP Industries’ investment...

What Banc of California’s upcoming earnings mean for shareholders Banc of California (BANC) reports its Q4 2025 results after the market closes today, and this earnings release is in focus after recent quarters where the bank outpaced revenue and earnings expectations. Analysts are looking for Q4 revenue growth of 9.2% year on year and adjusted earnings of $0.37 per share, so tonight’s update will show how the bank is tracking against those expectations. See our latest analysis for Banc of...